After Oxa treatment, Gli3+/– mice had attenuated epidermal and dermal thickening with decreased hyperkeratosis and parakeratosis compared with WT mice (Figure 2H), and serum IgE levels were significantly decreased (Figure 2I). The gene discussed is IGHE; the disease is Hyperkeratosis.